immediate action Recalls

B. Braun Medical Recalls 3,120 IV Administration Sets for Infusomat Pumps in 2025

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall 66,792 Units for Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set 490245 Recalled for Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Recalls 31,392 IV Administration Sets for Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall 122,232 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical IV Administration Set Recall 2025 Affects 6,768 Units Over Backflow Risk

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical IV Administration Set Recall 36,936 Units for Backflow and Occlusion Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall for 45,288 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical Recalls 98,568 IV Administration Sets for Backflow and Occlusion Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall for 5,952 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall 2025 Affects 259,392 Units

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

Philips CT Scanner Recalled Over Potential Detachment Hazard

B Braun Medical Recalls 12,168 IV Administration Sets for Backflow and Occlusion Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

Philips Incisive CT Recall 2025: 2,341 CT Scanners Over Loose Tube Heat Exchanger Screws

B Braun Medical Recalls 12,200 IV Administration Sets for Backflow and Occlusion Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall Affects 286,400 Units Across Global Pumps (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical IV Administration Set Recall Affects 41,976 Units Worldwide (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall for 1,250 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall 2025 Affects 5,900 Units Over Backflow Risk

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Recalls 7,008 IV Administration Sets for Infusomat Space Pumps (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).